GO
Loading...

Novo Nordisk Quarter Three Profit Beats

Wednesday, 31 Oct 2012 | 4:30 AM ET

Jesper Brandgaard, CFO of Danish drug producer, Novo Nordisk, tells CNBC that another steady quarter from their insulin franchise contributed to a good overall third quarter.